Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Summary
LA JOLLA, Calif., May 01, 2026 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology innovator developing novel therapies to treat severe autoimmune...
Original reporting
Open original sourceAFBytes is a read-only aggregator. Use the original source for full context and complete reporting.